北美视网膜成像设备市场预测至 2028 年 - 按设备类型（荧光血管造影、眼底相机和光学相干断层扫描）和最终用户（医院和诊所、门诊手术中心、专业眼科护理中心和其他最终用户）
No. of Pages: 113 | Report Code: TIPRE00028662 | Category: Life Sciences
No. of Pages: 113 | Report Code: TIPRE00028662 | Category: Life Sciences
糖尿病患病率的不断上升导致成人糖尿病视网膜病变和失明的患病率不断上升。根据国际糖尿病联盟 (IDF) 2021 年数据，近 5.37 亿成年人（20 至 79 岁）患有糖尿病。预计到 2030 年，糖尿病患者总数将增至 6.43 亿，到 2045 年将增至 7.83 亿。四分之一的糖尿病成人患者生活在低收入和中等收入国家。 IDF的报告还指出，大多数国家有最大比例的人患有2型糖尿病。近 79% 的 2 型糖尿病患者生活在低收入和中等收入国家。因此，根据 IDF 的预测和统计，糖尿病性视网膜病变预计将在未来几年成为主要的眼部健康状况或疾病。
COVID-19 大流行给该地区的医疗机构带来了前所未有的运营和临床挑战。而且，重点从眼病治疗转向COVID-19诊断和治疗设备，导致市场增速出现一定程度的下滑。视网膜手术患者需要重要的 ICU 资源，并且也可能属于 COVID-19 并发症的风险类别。视网膜疾病治疗的持续疗效取决于重复和定期治疗，直到疾病活动停止。不过，受疫情影响，大多数医院和手术中心都考虑取消或推迟包括视网膜手术在内的择期手术。
此外，市场参与者的业务运营也受到干扰，产品需求下降对北美视网膜成像设备市场产生了轻微的负面影响。因此，在推出 COVID-19 疫苗之前，COVID-19 对市场产生了一定的负面影响。然而，从长远来看，随着疫苗接种计划的确定和传播率的下降，医疗保健系统预计将恢复正常，并在预测期内对视网膜成像设备的需求增加。
< p>借助新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动北美视网膜成像设备市场实现大幅复合年增长率。
Strategic insights for North America Retinal Imaging Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 629.0 Million |
| Market Size by 2028 | US$ 936.7 Million |
| Global CAGR (2021 - 2028) | 5.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 设备类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Retinal Imaging Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Retinal Imaging Devices Market is valued at US$ 629.0 Million in 2021, it is projected to reach US$ 936.7 Million by 2028.
As per our report North America Retinal Imaging Devices Market, the market size is valued at US$ 629.0 Million in 2021, projecting it to reach US$ 936.7 Million by 2028. This translates to a CAGR of approximately 5.9% during the forecast period.
The North America Retinal Imaging Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Retinal Imaging Devices Market report:
The North America Retinal Imaging Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Retinal Imaging Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Retinal Imaging Devices Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Retinal Imaging Devices Market
